Zhejiang
603229.SSZhejiang Ausun Pharmaceutical Co., Ltd. Price (603229.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
593,069,389
(5.4134)%Revenue and Profitability
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 58,930,963 | 120,948,643 | 201,417,276 | 262,666,048 | 198,841,958 | 240,188,298 | 243,885,062 | 307,914,615 | 409,249,350 | 569,698,344 | 764,547,389 | 816,765,083 |
| Net Income | 2,293,872 | 15,552,699 | 21,501,013 | 60,865,088 | 57,328,094 | 53,011,517 | 43,864,090 | 56,386,592 | 86,836,031 | 145,930,186 | 235,375,827 | 253,901,967 |
| FCF USD | -38,677,612 | -20,979,700 | -1,631,510 | 10,822,832 | 50,419,938 | -7,580,193 | -43,550,242 | 38,104,381 | 45,515,332 | -136,952,245 | -151,346,830 | 58,377,521 |
| OCF USD | -1,138,300 | 15,729,900 | 21,450,356 | 53,626,069 | 93,207,588 | 46,784,777 | 11,503,536 | 87,729,755 | 138,470,268 | 173,900,860 | 120,567,033 | 221,847,783 |
Financial Health - DEBT
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 1.75 | 0.00 | 0.08 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.31 | 0.01 |
| D/E | 4.78 | 2.14 | 0.97 | 0.29 | 0.25 | 0.11 | 0.12 | 0.07 | 0.04 | 0.09 | 0.17 | 0.14 |
| CA/CL | 0.36 | 0.41 | 0.61 | 1.05 | 1.29 | 2.99 | 2.73 | 2.59 | 4.02 | 1.92 | 1.52 | 2.17 |
| TA/TL | 1.09 | 1.23 | 1.43 | 1.88 | 2.20 | 4.20 | 3.92 | 3.68 | 5.42 | 3.15 | 2.71 | 3.64 |
| Total Debt | 49,500,000 | 70,500,000 | 75,640,000 | 54,880,000 | 60,600,000 | 62,487,721 | 72,000,000 | 44,958,012 | 41,042,463 | 109,932,577 | 242,023,464 | 302,299,119 |
Management Performance
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 3.91% | 15.27% | 13.44% | 27.18% | 19.09% | 9.31% | 6.46% | 8.69% | 7.45% | 10.67% | 13.70% | 10.24% |
| ROE | 22.15% | 47.26% | 27.49% | 32.36% | 23.56% | 9.38% | 7.34% | 8.74% | 7.71% | 11.63% | 16.11% | 11.86% |
| ROA | 0.00% | 8.70% | 8.27% | 15.14% | 12.85% | 7.15% | 5.47% | 6.36% | 6.28% | 7.93% | 10.17% | 8.60% |
| NM % | 3.89% | 12.86% | 10.67% | 23.17% | 28.83% | 22.07% | 17.99% | 18.31% | 21.22% | 25.62% | 30.79% | 31.09% |
| FCF / R% | 0.00% | -17.35% | -0.81% | 4.12% | 25.36% | -3.16% | -17.86% | 12.37% | 11.12% | -24.04% | -19.80% | 7.15% |
| FCF / NI% | -1,686.11% | -134.89% | -7.59% | 17.78% | 87.95% | -14.30% | -99.28% | 67.58% | 52.42% | -93.85% | -64.30% | 22.99% |
| Operating Margin (OM) | 0.00 | 0.13 | 0.07 | 0.26 | 0.55 | 0.66 | 0.76 | 0.74 | 0.72 | 0.72 | 0.77 | 0.94 |
Per Share
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.03 | 0.11 | 0.14 | 0.17 | 0.15 | 0.11 | 0.08 | 0.11 | 0.17 | 0.26 | 0.42 | 0.43 |
| SPS | 0.70 | 0.83 | 1.28 | 0.73 | 0.51 | 0.51 | 0.46 | 0.58 | 0.78 | 1.02 | 1.36 | 1.38 |
| OCPS | -0.01 | 0.11 | 0.14 | 0.15 | 0.24 | 0.10 | 0.02 | 0.17 | 0.26 | 0.31 | 0.21 | 0.37 |
| FCPS | -0.46 | -0.14 | -0.01 | 0.03 | 0.13 | -0.02 | -0.08 | 0.07 | 0.09 | -0.24 | -0.27 | 0.10 |
| BVPS | 0.12 | 0.22 | 0.50 | 0.53 | 0.62 | 1.20 | 1.13 | 1.22 | 2.15 | 2.24 | 2.60 | 3.61 |
Per Share - CAGR
| Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.03 | 0.11 | 0.14 | 0.17 | 0.15 | 0.11 | 0.08 | 0.11 | 0.17 | 0.26 | 0.42 | 0.43 |
| CAGR-SPS | 0.70 | 0.83 | 1.28 | 0.73 | 0.51 | 0.51 | 0.46 | 0.58 | 0.78 | 1.02 | 1.36 | 1.38 |
| CAGR-OCPS | -0.01 | 0.11 | 0.14 | 0.15 | 0.24 | 0.10 | 0.02 | 0.17 | 0.26 | 0.31 | 0.21 | 0.37 |
| CAGR-FCPS | -0.46 | -0.14 | -0.01 | 0.03 | 0.13 | -0.02 | -0.08 | 0.07 | 0.09 | -0.24 | -0.27 | 0.10 |
| CAGR-BVPS | 0.12 | 0.22 | 0.50 | 0.53 | 0.62 | 1.20 | 1.13 | 1.22 | 2.15 | 2.24 | 2.60 | 3.61 |